2016 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Study Evaluates Impact of Age and Urgency on TEVAR Risk in Elderly

July 26, 2016 -- A study of the impact of age and urgency on survival after thoracic endovascular aortic repair (TEVAR) was published by Paola De Rango, MD, et al in the Journ…

Codman Neuro to Distribute InNeuroCo’s Devices to Treat Hemorrhagic Stroke

July 26, 2016 -- Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced that it has entered into an agreement with InNeuroCo, Inc. for exclusive Uni…

Penumbra Launches Ace 68 Reperfusion Catheter for Stroke Thrombectomy

July 25, 2016 -- Penumbra, Inc. announced commercial availability of the Ace 68 reperfusion catheter, part of the fully integrated Penumbra system, in the United States. …

AV Medical Introduces Chameleon PTA Balloon Catheter in the United States

July 18, 2016 -- AV Medical Technologies Ltd. announced today that it has commenced cases in the United States as part of its limited launch of the Chameleon angioplasty ballo…

FDA Approves Vasorum’s Celt ACD Vascular Closure Device

July 21, 2016 -- Vasorum Ltd. announced US Food and Drug Administration approval of the Celt ACD vascular closure device, which is indicated for arterial puncture closure in b…

SNIS Prepares to Convene Annual Meeting in Boston

July 21, 2016 -- The Society of NeuroInterventional Surgery (SNIS) announced studies to be presented at the SNIS 13th Annual Meeting meeting, which will be held July…

Click here for more News coverage

Current Supplements

Sponsored by GORE & ASSOCIATES

Value-Based Decisions for Dialysis Access

How practitioners of dialysis access creation and intervention are improving patient outcomes while reducing system costs.

Summer Supplement

Sponsored by Medtronic

Uncomplicating EVAR

Experts share how EndoAnchors are empowering physicians and aortic centers with unparalleled capabilities in the treatment of patients with aortic disease.

Current European Supplement

Sponsored by Spectranetics

Evidence From the Next-Generation DCB

More With Less

Featured Center

 

Embolization

advertisement

 

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.